Get even more insights on these trends and the topics that matter most to manufacturers at KnowledgeDriven.com.
Claire Biermaas
VP, Divisional Marketing,
Customer Experience & Innovation
AmerisourceBergen
We needed to organize ourselves around one goal: deliver an experience that allows our customers to commit to us forever.
Barry Fortner, PhD
President
Oncology Supply
We’ve gone from dreaming of point of care data to exchanging ones and zeroes with virtually everyone in the marketplace.
Matt Sarnes, PharmD
SVP, Commercial Consulting
Xcenda
Xcenda
There's a lot of great data that we're creating together, which the payer community, physicians (because of the shift of risk to them), and ultimately patients will be asking for. We need to make sure that we work together to deliver that message effectively.
Brian Nightengale, RPh, PhD
President
Good Neighbor Pharmacy
[Independent pharmacies] are looking to expand their clinical practices – how we can help them, for example, focus through education and services and solutions on particular therapeutic areas and become that local expert, especially in those under-served areas. Immunizations and diabetes care and increasingly more complex areas such as HIV…That's the wave of the future and the wave of the current.
It’s happening across the healthcare continuum in many different forms – innovative therapies, new patient support models, digital transformation, technology and operational advances and more. How will all stakeholders continue to push each other to go further, faster and do even more toward the goal of improving product access, increasing supply chain efficiency and, ultimately, enhancing patient lives?
Innovation
Healthcare remains a hotbed
of innovation.
Guy Payette
President
Innomar Strategies
Each market has their own licensing and regulatory process, so manufacturers need to begin planning for international market access as early as possible during the development phase.
Doug Cook
President, Global Specialty Logistics
AmerisourceBergen Specialty Group
Direct-to-patient models have been increasing patient recruitment by 60% or more, reducing on-site visits for patients and maintaining patient retention at 95% or more. It has proven to overcome the two largest issues plaguing clinical trials: patient recruitment and retention.
Rich Tremonte
SVP, Global Generic Pharmaceuticals
Global Sourcing and Manufacturer Relations
AmerisourceBergen
We now have a way to bring all the product knowledge we’ve learned, in all of these countries, to bear. And although each product and each market is specific, you’re going to continue to see larger strategies at the global level.
Consider where patients are presenting for care
Leverage experiential data on launch successes and failures
Engage industry partners early to understand the customer viewpoint
Three Considerations
The ever-expanding specialty pipeline has more and more manufacturers wanting to expand into global markets. But how do you address the access barriers that can arise when doing business in global markets? The answer may exist in thinking globally while accommodating local patients and regulatory bodies – and having a partner with reach that can help you solve access challenges for one patient or one million.
"Glocalization"
Healthcare is increasingly global, but also increasingly local.
Barry Fortner, PhD
President
Oncology Supply
The algebra of oncology right now is mind-blowing.
Brad Tallamy
Director, Government Affairs
AmerisourceBergen
Patients pay the price of bad policy.
Rick Demers, RPh, MS
Assistant Executive Hospital Director, Clinical Services
University of Pennsylvania
They're very, very sick and they're on very complex medications. Access and adherence is a huge issue for these patients and we all need to think about them and not let them get lost in the whole mix.
Tech and tools allow providers to continue fulfilling their mission of delivering quality care, but that doesn’t mean it’s getting easier. Competitive pressures, regulatory, legislative and reimbursement concerns, as well as increasingly complex treatment regimens all contribute to an environment that is difficult to navigate. Providers are eager to collaborate with manufacturers to co-design programs that will meet all stakeholders’ needs.
The provider experience
The continuing complexity of the provider experience.
Tony Martin
SVP, Client Strategy
Lash Group
One trend that we're seeing in the marketplace now is the nurse navigator ... the manner in which a nurse engages a patient is a really special thing. There is no greater advocate for that patient than the nurse.
Donna Gilbert
Vice President, Strategic Accounts
Global Sourcing and Manufacturer Relations
AmerisourceBergen
We promise that if you start with the patient first, you will have successful growth strategies.
Steve Collis
Chairman, President & CEO
AmerisourceBergen
To all the manufacturers who actively and purposefully work to change patients’ lives—even as you work to create shareholder value—I am here to tell you: AmerisourceBergen stands with you.
Akin Odutola
SVP, Specialty & Branded Product Access
Global Sourcing and Manufacturer Relations
AmerisourceBergen
I ask this question: If you build it, will they come? If you build a network, will the patients show? Will all the patients that need the medication, or all the patients that should be on the medication, present in the network? Will prescribers write for your script in that network? Are you leaving opportunity behind?
Pete Belden
President
ICS
Supply chains, rather than being linear, are becoming circular. The patient is not just the patient but also a critical element of the manufacturing of the molecule.
Educational
Physical
Cultural / Communications
Financial
Logistical
Psychological / Emotional
Manufacturers and providers must address the
whole patient, not just the clinical aspects of their disease.
Simply putting a product on the market isn’t enough anymore.
Are the patients who need therapies able to access them? Where are they receiving care? What are their financial and emotional needs? From site of care and treatment decisions to support services and distribution networks, more and more manufacturers are weighing the patient experience in product commercialization and access strategy to support the whole patient along the full therapeutic continuum.
The patient experience
Making the patient journey
a priority.
Amy Grogg, PharmD
SVP, Strategy & Commercialization
AmerisourceBergen Specialty Group
We have a shared purpose – making certain we can have an impact on patient lives.
Steve Collis
Chairman, President & CEO
AmerisourceBergen
The current management at AmerisourceBergen is steeped in this commercialization mindset – and the more challenging it becomes for you, the more you can rely on us.
Peyton Howell
EVP & President,
Global Sourcing and Manufacturer Relations
AmerisourceBergen
Our primary focus is to drive consistent, reliable access to the therapies and treatments patients need. And our investments are focused on supporting your success and enabling the full potential of your product. It’s this aligned model and shared purpose that supports and drives our mutual success.
True partners have shared purpose, shared trust in each other’s expertise and a shared commitment to common goals. As competition grows and products, payer relations and channel strategy become more complex, manufacturers and commercialization partners will work together earlier in the commercialization process. True commercialization partners will be available to problem-solve at each crucial step.
Partnership
The value of a true partner.
Steve Collis
Chairman, President & CEO
AmerisourceBergen
Each person in this room shares the goal of improving patient lives.
The stakes are high. The scrutiny is real. How can pharma adapt, succeed and make a difference in patient lives in the face of market pressures?
At ThinkLive 2016, more than 500 market access, supply chain and brand management professionals joined AmerisourceBergen to access insights that will help them find product success in the coming year and beyond. Here, we share the key themes from the event.
Propelling Product Success in 2017
